fbpx Skip to main content

Member's Profile

Greenwich Biosciences

5750 Fleet St
Carlsbad,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2016
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Greenwich Biosciences
Biotech Company
Greenwich Biosciences is the US leader in the development and commercialization of prescription cannabinoid medicines to address serious medical conditions. Along with parent company GW Pharmaceuticals, we have been advancing cannabinoid science for more than two decades, with much of what is known about cannabinoids discovered by our researchers. In addition to lead product – EPIDIOLEX® (cannabidiol) oral solution, indicated for the treatment of seizures associated with three rare disorders – we have a robust pipeline of cannabinoid-derived therapies for serious illnesses (e.g., Rett syndrome, spasticity associated with multiple sclerosis and spinal cord injury, post-traumatic stress disorder, schizophrenia and autism spectrum disorders).
Related News
No related news posted by this Member